
PetIQ PETQ
Annual report 2023
added 02-29-2024
PetIQ EBITDA per Share 2011-2026 | PETQ
Annual EBITDA per Share PetIQ
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.8 | 0.52 | 1.95 | 1.13 K | 0.913 | 1.36 | 1.28 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.13 K | 0.52 | 162 |
Quarterly EBITDA per Share PetIQ
| 2023-Q3 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.69 | - | -1.33 | 0.99 | 0.63 | - | 0.89 | 1.29 | 0.74 | - | 0.63 | 0.61 | 0.25 | -0.54 | 0.29 | 0.67 | 0.37 | -0.23 | 0.93 | 0.92 | -0.05 | - | 0.34 | 0.63 | 0.43 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.29 | -1.33 | 0.436 |
EBITDA per Share of other stocks in the Drug manufacturers industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
AcelRx Pharmaceuticals
ACRX
|
-0.32 | - | 7.5 % | $ 6.35 M | ||
|
Alimera Sciences
ALIM
|
0.27 | - | - | $ 142 M | ||
|
Aerie Pharmaceuticals
AERI
|
-0.86 | - | - | $ 754 M | ||
|
Agile Therapeutics
AGRX
|
-9.17 | - | 10.11 % | $ 58.2 M | ||
|
Adamis Pharmaceuticals Corporation
ADMP
|
-0.16 | - | 0.86 % | $ 117 M | ||
|
Aurora Cannabis
ACB
|
-1.67 | $ 3.3 | -0.3 % | $ 86.3 M | ||
|
China Pharma Holdings
CPHI
|
-0.11 | $ 0.63 | - | $ 11 M | ||
|
Catalent
CTLT
|
-1.44 | - | - | $ 11.5 B | ||
|
Athenex
ATNX
|
-10 | - | -23.39 % | $ 1.76 M | ||
|
Avadel Pharmaceuticals plc
AVDL
|
-0.42 | - | - | $ 2.06 B | ||
|
Cronos Group
CRON
|
-0.504 | $ 2.55 | 1.19 % | $ 1.32 B | ||
|
DURECT Corporation
DRRX
|
-1.4 | - | - | $ 50.1 M | ||
|
Emergent BioSolutions
EBS
|
-11.7 | $ 8.04 | -0.12 % | $ 412 M | ||
|
Endo International plc
ENDP
|
1.3 | - | - | $ 28.9 M | ||
|
Evoke Pharma
EVOK
|
-2.22 | - | - | $ 36.6 M | ||
|
Calliditas Therapeutics AB (publ)
CALT
|
-10.3 | - | -0.1 % | $ 2.03 B | ||
|
HEXO Corp.
HEXO
|
-0.67 | - | 2.45 % | $ 38.1 M | ||
|
Cumberland Pharmaceuticals
CPIX
|
0.22 | $ 3.18 | 4.1 % | $ 44.7 M | ||
|
Pacira BioSciences
PCRX
|
0.12 | $ 22.82 | 0.75 % | $ 1.06 B | ||
|
Bausch Health Companies
BHC
|
6.1 | $ 4.97 | -2.55 % | $ 1.81 B | ||
|
Harrow Health
HROW
|
0.87 | $ 35.03 | 3.03 % | $ 1.29 B | ||
|
OptiNose
OPTN
|
-0.2 | - | - | $ 1.08 B | ||
|
Evolus
EOLS
|
-0.39 | $ 4.43 | -5.45 % | $ 286 M | ||
|
Rockwell Medical
RMTI
|
-0.22 | $ 1.04 | 1.96 % | $ 24.3 M | ||
|
SCYNEXIS
SCYX
|
-0.32 | $ 0.87 | -0.29 % | $ 43.4 M | ||
|
Eagle Pharmaceuticals
EGRX
|
6.31 | - | -39.89 % | $ 27.7 M | ||
|
Solid Biosciences
SLDB
|
-2.03 | $ 6.69 | -6.3 % | $ 585 M | ||
|
Sundial Growers
SNDL
|
-71 | $ 1.36 | -0.37 % | $ 3.37 M | ||
|
Sonoma Pharmaceuticals
SNOA
|
-2.88 | $ 2.34 | -8.24 % | $ 2.9 M | ||
|
Relmada Therapeutics
RLMD
|
-1.5 | $ 6.01 | 2.56 % | $ 237 M | ||
|
OrganiGram Holdings
OGI
|
-0.36 | $ 1.36 | 0.01 % | $ 402 M | ||
|
Tilray
TLRY
|
-2.22 | $ 6.57 | 1.86 % | $ 4.06 B | ||
|
PLx Pharma
PLXP
|
-1.72 | - | -27.8 % | $ 2.56 M | ||
|
ProPhase Labs
PRPH
|
1.79 | - | - | $ 5.07 M | ||
|
Jupiter Wellness
JUPW
|
0.01 | - | - | $ 33.6 M | ||
|
TherapeuticsMD
TXMD
|
-0.73 | $ 2.28 | -1.2 % | $ 23.8 M | ||
|
Radius Health
RDUS
|
-1.13 | - | - | $ 1.42 B | ||
|
Veru
VERU
|
-0.27 | $ 2.28 | -0.87 % | $ 308 M | ||
|
Viatris
VTRS
|
2.92 | $ 13.43 | 1.02 % | $ 16.1 B | ||
|
Lannett Company
LCI
|
-3.52 | - | 1.15 % | $ 7.11 M | ||
|
cbdMD
YCBD
|
-0.66 | $ 0.78 | 1.3 % | $ 3.36 M | ||
|
Organogenesis Holdings
ORGO
|
0.09 | $ 2.43 | -1.62 % | $ 320 M | ||
|
Neoleukin Therapeutics
NLTX
|
-106 | - | - | $ 193 M | ||
|
Perrigo Company plc
PRGO
|
-5.67 | $ 9.65 | 0.89 % | $ 1.34 B | ||
|
Canopy Growth Corporation
CGC
|
-0.89 | $ 0.94 | -2.32 % | $ 101 M | ||
|
Assertio Holdings
ASRT
|
1.32 | $ 15.95 | 13.93 % | $ 102 M | ||
|
Recro Pharma
REPH
|
0.05 | - | -4.76 % | $ 65.3 M | ||
|
Tricida
TCDA
|
-2.97 | - | - | $ 3.25 M | ||
|
Zynerba Pharmaceuticals
ZYNE
|
-0.82 | - | - | $ 55.5 M |